Apoptosis

, Volume 11, Issue 7, pp 1161–1173 | Cite as

RhoA and p38 MAPK mediate apoptosis induced by cellular cholesterol depletion

  • Laura Calleros
  • Marina Lasa
  • Francisco J. Rodríguez-Álvarez
  • María J. Toro
  • Antonio Chiloeches
Reports
First Online:

Abstract

Cholesterol is essential for cell viability, and homeostasis of cellular cholesterol is crucial to various cell functions. Here we examined the effect of cholesterol depletion on apoptosis and the mechanisms underlying this effect in NIH3T3 cells. We show that chronic cholesterol depletion achieved with lipoprotein-deficient serum (LPDS) and 25-hydroxycholesterol (25-HC) treatment resulted in a significant increase in cellular apoptosis and caspase-3 activation. This effect is not due to a deficiency of nonsterol isoprenoids, intermediate metabolites of the cholesterol biosynthetic pathway, but rather to low cholesterol levels, since addition of cholesterol together with LPDS and 25-HC nearly abolished apoptosis, whereas addition of farnesyl pyrophosphate or geranylgeranyl-pyrophosphate did not reverse the cell viability loss induced by LPDS plus 25-HC treatment. These effects were accompanied by an increase in ERK, JNK and p38 MAPK activity. However, only the inhibition of p38 MAPK with the specific inhibitor SB203580 or the overexpression of a kinase defective MKK6 resulted in a significant decrease in apoptosis and caspase-3 cleavage induced by cholesterol depletion. Furthermore, LPDS plus 25-HC increased RhoA activity, and this effect was reversed by addition of exogenous cholesterol. Finally, overexpression of the dominant negative N19RhoA inhibited p38 MAPK phosphorylation and apoptosis induced by low cholesterol levels. Together, our results demonstrate that cholesterol depletion induces apoptosis through a RhoA- and p38 MAPK-dependent mechanism.

Keywords

Apoptosis Cholesterol Lipoprotein-deficient serum 25-HC ERK JNK p38 MAPK RhoA 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brown MS, Goldstein JL (1980) Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J Lipid Res 21:505–517PubMedGoogle Scholar
  2. 2.
    Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343:425–430PubMedCrossRefGoogle Scholar
  3. 3.
    Quesney-Huneeus V, Alack HA, Siperstein MD, et al (1983) The dual role of mevalonate in the cell cycle. J Biol Chem 258:378–385PubMedGoogle Scholar
  4. 4.
    Habenicht AJR, Grommet JA, Ross R (1980) Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J Biol Chem 255:5134–5140PubMedGoogle Scholar
  5. 5.
    Fairbanks KP, Witte LD, Goodman DS (1984) Relationship between mevalonate and mitogenesis in human fibroblasts stimulated with platelet-derived growth factor. J Biol Chem 259:1546–1551PubMedGoogle Scholar
  6. 6.
    Siperstein MD (1984) Role of cholesterogenesis and isoprenoid synthesis in DNA replication and cell growth. J Lipid Res 252:1462–1468Google Scholar
  7. 7.
    Cuts JL, Scalpel TJ, Wanton J, Bankhurst AD (1989) Role of mevalonic acid in the regulation of natural killer cell cytotoxicity. J Cell Physiol 139:550–557CrossRefGoogle Scholar
  8. 8.
    Garcia-Roman N, Alvarez AM, Toro MJ, Montes A, Lorenzo MJ (2001) Lovastatin induces apoptosis of spontaneously immortalized rat brain neuroblasts: Involvement of nonsterol isoprenoid biosynthesis inhibition. Mol Cell Neurosci 17:329–341PubMedCrossRefGoogle Scholar
  9. 9.
    Padayatty SJ, Marcelli T, Shao TC, Cunningham GR (1997) Lovastatin-induced apoptosis in prostate stromal cells. J Clin Endocrinol Metab 82:1434–1439PubMedCrossRefGoogle Scholar
  10. 10.
    Jones KD, Coulder WT, Hinton DR, et al (1994) Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells. Biochem Biophys Res Commun 205:1681–1687PubMedCrossRefGoogle Scholar
  11. 11.
    Dimitroulakos J, Yeger H (1996) HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells. Nat Med 2:326–333PubMedCrossRefGoogle Scholar
  12. 12.
    Satoh T, Isobe H, Ayukawa K, Sakai H, Nawara H (1996) The effects of pravastatin, an HMG-CoA reductase inhibitor, on cell viability and DNA production of rat hepatocytes. Life Sci 59:1103–1108PubMedCrossRefGoogle Scholar
  13. 13.
    Michikawa M, Yanagisawa K (1999) Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death. J Neurochem 72:2278–2285PubMedCrossRefGoogle Scholar
  14. 14.
    Sponne I, Fifre A, Koziel V, Oster T, Olivier JL, Pillot T (2004) Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of amyloid-beta peptide. FASEB J 18:836–838PubMedGoogle Scholar
  15. 15.
    Yang L, Sinensky MS (2000) 25-Hydroxycholesterol activates a cytochrome c release-mediated caspase cascade. Biochem Biophys Res Commun 278:557–563PubMedCrossRefGoogle Scholar
  16. 16.
    Lim HK, Kang HK, Yoo ES, et al. (2003) Oxysterols induce apoptosis and accumulation of cell cycle at G(2)/M phase in the human monocytic THP-1 cell line. Life Sci 72:1389–1399PubMedCrossRefGoogle Scholar
  17. 17.
    Rusinol AE, Thewke D, Liu J, Freeman N, Panini SR, Sinensky MS (2004) AKT/protein kinase B regulation of BCL family members during oxysterol-induced apoptosis. J Biol Chem 279:1392–1399PubMedGoogle Scholar
  18. 18.
    Brown DA, London E (1998) Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 14:111–136PubMedCrossRefGoogle Scholar
  19. 19.
    Chiloeches A, Usera F, Lasa M, Ropero S, Montes A, Toro MJ (1997) Effect of mevalonate availability on the association of G-protein alpha-subunits with the plasma membrane in GH4C1 cells. FEBS Lett 401:68–72PubMedCrossRefGoogle Scholar
  20. 20.
    Ropero S, Chiloeches A, Montes A, Toro-Nozal MJ (2003) Cholesterol cell content modulates GTPase activity of G proteins in GH4C1 cell membranes. Cell Signal 15:131–138PubMedCrossRefGoogle Scholar
  21. 21.
    Breusegem SY, Halaihel N, Inoue M, et al (2005) Acute and chronic changes in cholesterol modulate Na-Pi cotransport activity in OK cells. Am J Physiol Renal Physiol 289:154–165CrossRefGoogle Scholar
  22. 22.
    Luegmayr E, Glantschnig H, Wesolowski GA, et al (2004) Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins. Cell Death Differ 1:108–118CrossRefGoogle Scholar
  23. 23.
    Bang B, Gniadecki R, Gajkowska B (2005) Disruption of lipid rafts causes apoptotic cell death in HaCaT keratinocytes. Exp Dermatol 14:266–272PubMedCrossRefGoogle Scholar
  24. 24.
    Griadecki R (2004) Depletion of membrane cholesterol causes ligand-independent activation of Fas and apoptosis. Biochem Biophys Res Commun 320:165–169CrossRefGoogle Scholar
  25. 25.
    Sarker KP, Maruyama I (2003) Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: Possible involvement of lipid rafts. Cell Mol Life Sci 60:1200–1208PubMedGoogle Scholar
  26. 26.
    Biswas KK, Sarker KP, Abeyama K, et al (2003) Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis. Hepatology 38:1167–1177PubMedCrossRefGoogle Scholar
  27. 27.
    Kyriakis JM, Avruch J (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81:807–869PubMedGoogle Scholar
  28. 28.
    Roux PP, Blenis J (2004) ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions. Microbiol. Mol Biol Rev 68:320–344CrossRefGoogle Scholar
  29. 29.
    Wada T, Penninger JM (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23:2838–2849PubMedCrossRefGoogle Scholar
  30. 30.
    Bar-Sagi D, Hall A (2000) Ras and Rho GTPases: A family reunion. Cell 103:227–238PubMedCrossRefGoogle Scholar
  31. 31.
    Takai Y, Sasaki T, Matozaki T (2001) Small GTP-binding proteins. Physiol Rev 81:153–208PubMedGoogle Scholar
  32. 32.
    Kaibuchi K, Kuroda S, Amano M (1999) Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 68:459–486PubMedCrossRefGoogle Scholar
  33. 33.
    Aznar S, Lacal JC (2001) Rho signals to cell growth and apoptosis. Cancer Lett 165:1–10PubMedCrossRefGoogle Scholar
  34. 34.
    Malliri A, Collard JG (2003) Role of Rho-family proteins in cell adhesion and cancer. Curr Opin Cell Biol 15:583–589PubMedCrossRefGoogle Scholar
  35. 35.
    Park HJ, Kong D, Iruela-Arispe L, Begley U, Tang D, Galper JB (2002) 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Circ Res 91:143–150PubMedCrossRefGoogle Scholar
  36. 36.
    Fessler MB, Arndt PG, Frasch SC, et al (2004) Lipid rafts regulates lipopolysaccharide-induced activation of Cdc42 and inflammatory functions of the human neutrophil. J Biol Chem 279:39989–39998PubMedCrossRefGoogle Scholar
  37. 37.
    Senokuchi T, Matsumura T, Sakai M, et al (2005) Statins suppress oxidized low density lipoprotein-induced macrophage proliferation by inactivation of the small G protein-p38 MAPK pathway. J Biol Chem 280:6627–6633PubMedCrossRefGoogle Scholar
  38. 38.
    Gingras D, Gauthier F, Lamy, S, Desrosiers RR, Beliveau R (1998) Localization of RhoA GTPase to endothelial caveolae-enriched membrane domains. Biochem Biophys Res Commun 247:888–893PubMedCrossRefGoogle Scholar
  39. 39.
    Michaely PA, Mineo C, Ying YS, Anderson RG (1999) Polarized distribution of endogenous Rac1 and RhoA at the cell surface. J Biol Chem 274:21430–21436PubMedCrossRefGoogle Scholar
  40. 40.
    Utech M, Hobbel G, Rust S, Reinecke H, Assmann G, Walter M (2001) Accumulation of RhoA, RhoB, RhoG, and Rac1 in fibroblasts from Tangier disease subjects suggests a regulatory role of Rho family proteins in cholesterol efflux. Biochem Biophys Res Commun 280:229–236PubMedCrossRefGoogle Scholar
  41. 41.
    Girao H, Pereira P, Ramalho J, Quinlan R, Prescott A (2003) Cholesterol oxides mediated changes in cytoskeletal organisation involves Rho GTPases. Exp Cell Res 291:502–513PubMedCrossRefGoogle Scholar
  42. 42.
    Sanz-Moreno V, Casar B, Crespo P (2003) p38alpha isoform Mxi2 binds to extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase and regulates its nuclear activity by sustaining its phosphorylation levels. Mol Cell Biol 9:3079– 3090CrossRefGoogle Scholar
  43. 43.
    Rothblat GH, Bamberger M, Phillips MC (1986) Reverse cholesterol transport. Methods Enzymol 129:628–644PubMedCrossRefGoogle Scholar
  44. 44.
    Gamble W, Vaughan M, Kruth HS, Avigan J (1978) Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells. J Lipid Res 19:1068–1070PubMedGoogle Scholar
  45. 45.
    Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF (2001) Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol 3:339–345PubMedCrossRefGoogle Scholar
  46. 46.
    Galaria II, Fegley AJ, Nicholl SM, Roztocil E, Davies MG (2004) Differential regulation of ERK1/2 and p38(MAPK) by components of the Rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration. J Surg Res 122:173–179PubMedCrossRefGoogle Scholar
  47. 47.
    Yamauchi J, Tsujimoto G, Kaziro Y, Itoh H (2001) Parallel regulation of mitogen-activated protein kinase kinase 3 (MKK3) and MKK6 in Gq-signaling cascade. J Biol Chem 276:23362–23372PubMedCrossRefGoogle Scholar
  48. 48.
    Landis MS, Patel HV, Capone JP (2002) Oxysterol activators of liver X receptor and 9-cis-retinoic acid promote sequential steps in the synthesis and secretion of tumor necrosis factor-a from human monocytes. J Biol Chem 277:4713–4721PubMedCrossRefGoogle Scholar
  49. 49.
    Maxwell KN, Soccio RE, Duncan EM, Sehayek E, Breslow JL (2003) Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice. J Lipid Res 44:2109–2119PubMedCrossRefGoogle Scholar
  50. 50.
    Kawabe J, Okumura S, Lee MC, Sadoshima J, Ishikawa Y (2004) Translocation of caveolin regulates stretch-induced ERK activity in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 286:1845–1852CrossRefGoogle Scholar
  51. 51.
    Kabouridis PS, Janzen J, Magee AL, Ley SC (2000) Cholesterol depletion disrupts lipid rafts and modulates the activity of multiple signaling pathways in T lymphocytes. Eur J Immunol 30:954–963PubMedCrossRefGoogle Scholar
  52. 52.
    Furuchi T, Anderson RG (1998) Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J Biol Chem 273:21099–21104PubMedCrossRefGoogle Scholar
  53. 53.
    Ares MP, Porn-Ares MI, Moses S, Nilsson J, et al (2000) 7beta-hydroxycholesterol induces Ca(2+) oscillations, MAP kinase activation and apoptosis in human aortic smooth muscle cells. Atherosclerosis 153:23–35PubMedCrossRefGoogle Scholar
  54. 54.
    Yoon JH, Canbay AE, Werneburg NW, Lee SP, Gores GJ (2004) Oxysterols induce cyclooxygenase-2 expression in cholangiocytes:implications for biliary tract carcinogenesis. Hepatology 39:732–738PubMedCrossRefGoogle Scholar
  55. 55.
    Jans R, Atanasova G, Jadot M, Poumay Y (2004) Cholesterol depletion upregulates involucrin expression in epidermal keratinocytes through activation of p38. J Invest Dermatol 123:564–573PubMedCrossRefGoogle Scholar
  56. 56.
    Bulavin DV, Saito S, Hollander MC, et al (1999) Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J 18:6845–6854PubMedCrossRefGoogle Scholar
  57. 57.
    Ono K, Han J (2000) The p38 signal transduction pathway: Activation and function. Cell Signalling 12:1–13PubMedCrossRefGoogle Scholar
  58. 58.
    Marinissen MJ, Chiariello M, Gutkind JS (2001) Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway. Genes Dev 15:535–553PubMedCrossRefGoogle Scholar
  59. 59.
    Wang J, Fan J, Laschinger C, Arora PD, Kapus A, Seth A, McCulloch CA (2005) Smooth muscle actin determines mechanical force-induced p38 activation. J Biol Chem 280:7273–7284PubMedCrossRefGoogle Scholar
  60. 60.
    Agarwal B, Halmos B, Feoktistov AS, et al (2002) Mechanism of lovastatin-induced apoptosis in intestinal epithelial cells. Carcinogenesis 23:521–528PubMedCrossRefGoogle Scholar
  61. 61.
    Kaneta S, Satoh K (2003) All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells. Atherosclerosis 170:237–243PubMedCrossRefGoogle Scholar
  62. 62.
    Rombouts K, Kisanga E, Hellemans K, Wielant A, Schuppan D, Geerts A (2003) Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells. J Hepatol 38:564–572PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2006

Authors and Affiliations

  • Laura Calleros
    • 1
  • Marina Lasa
    • 2
  • Francisco J. Rodríguez-Álvarez
    • 1
  • María J. Toro
    • 1
  • Antonio Chiloeches
    • 1
  1. 1.Departamento de Bioquímica y Biología Molecular, Facultad de MedicinaUniversidad de AlcaláAlcalá de HenaresSpain
  2. 2.Instituto de Investigaciones BiomédicasCSIC-UAMMadridSpain

Personalised recommendations